Bezafibrate
UK matches:
- BEZAFIBRATE 200 MG FILM-COATED TABLETS (Leaflet)
- BEZAFIBRATE 200 MG TABLETS (Leaflet)
- BEZAFIBRATE 200MG FILM-COATED TABLETS (Leaflet)
- BEZAFIBRATE 200MG TABLETS (Leaflet)
- BEZAFIBRATE TABLETS 200MG (Leaflet)
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
C10AB02
CAS registry number (Chemical Abstracts Service)
0041859-67-0
Chemical Formula
C19-H20-Cl-N-O4
Molecular Weight
361
Therapeutic Category
Lipid lowering: Fibrate
Chemical Name
2-[p[2-(p-chlorobenzamido)etyl]phenoxy]-2-metylpropionic acid (WHO)
Foreign Names
- Bezafibratum (Latin)
- Bezafibrat (German)
- Bézafibrate (French)
- Bezafibrato (Spanish)
Generic Names
- Bezafibrate (OS: USAN, BAN, JAN)
- Bézafibrate (OS: DCF)
- Bezafibrato (OS: DCIT)
- BF-759 (IS)
- BM 15075 (IS)
- BRN 4267656 (IS)
- LO 44 (IS)
- UNII-Y9449Q51XH (IS)
- Bezafibrat (PH: Ph. Eur. 8)
- Bezafibrate (PH: BP 2016, JP XVI, Ph. Eur. 8)
- Bézafibrate (PH: Ph. Eur. 8)
- Bezafibratum (PH: Ph. Eur. 8)
Brand Names
- Abeita
Tasly, China - Anibesol SR
Zensei Yakuhin, Japan - Antifat
Astar, Taiwan - Befat
Standard, Taiwan - Befibrat
Hennig, Malta; Hennig Arzneimittel, Germany - Befibrat retard
Hennig Arzneimittel, Germany - Béfizal
Arrow, France - Béfizal LP
Arrow, France - Besastar SR
Towa Yakuhin, Japan - Betapid
Swiss Pharm, Taiwan - Bezachole
Pharmacare, South Africa - Bezacur
Hexal, Taiwan; Investi, Argentina - Bezafibrat - 1 A Pharma
1 A Pharma, Germany - Bezafibrat 1A Pharma retard
1A Pharma, Austria - Bezafibrat 400-Stada
STADA, China - Bezafibrat AbZ
AbZ-Pharma, Germany - Bezafibrat AL
Aliud, Germany - Bezafibrat AL retard
Aliud, Germany - Bezafibrat Arena
Arena, Romania - Bezafibrat dura
Mylan dura, Germany - Bezafibrat Farmex
Farmex, Romania - Bezafibrat Genericon retard
Genericon Pharma, Austria - Bezafibrat Heumann
Heumann, Germany - Bezafibrat HEXAL retard
Hexal, Germany - Bezafibrat ratiopharm retard
ratiopharm Arzneimittel, Austria - Bezafibrat Slavia Pharm
Slavia Pharm, Romania - Bezafibrat STADA
Stada Arzneimittel, Germany - Bezafibrat-CT
AbZ-Pharma, Germany - Bezafibrate
Hennig, Israel - Bezafibrate - Wan Gao Pharm
Wangao Pharmaceutical, China - Bezafibrate - Ya Tai Pharm
Yatai Pharmaceutical, China - Bezafibrate Actavis
Actavis UK, United Kingdom - Bezafibrate JG
Choseido Pharmaceutical, Japan - Bezafibrate SR Nichi-Iko
Nichi-Iko Pharmaceutical, Japan - Bezafibrate SR Sawai
Sawai Seiyaku, Japan - Bezafibrate SR Tanabe
Choseido Pharmaceutical, Japan - Bezafibrate Towa
Towa Yakuhin, Japan - Bezafibrato EG
EG, Italy - Bezafibrat-ratiopharm
ratiopharm, Germany - Bezagamma
Wörwag Pharma, Germany - Bezagamma retard
Wörwag Pharma, Germany - Bezalip
Actavis, United Arab Emirates; Actavis, Bahrain; Actavis, Ghana; Actavis, Greece; Actavis, Hong Kong; Actavis, Hungary; Actavis, Jordan; Actavis, Kenya; Actavis, Sri Lanka; Actavis, Malta; Actavis, Mauritius; Actavis, Malawi; Actavis, Namibia; Actavis, Nigeria; Actavis, Netherlands; Actavis, New Zealand; Actavis, Saudi Arabia; Actavis, Sudan; Actavis, Sweden; Actavis, Tanzania; Actavis, Uganda; Actavis, Zambia; Actavis, Zimbabwe; Actavis Group, Cyprus; Actavis Italy, Italy; Actavis UK, United Kingdom; AHPL, India; Akacia Healthcare, South Africa; Aurovitas, Portugal; Chugai Pharmaceutical, Japan; Roche, Oman; Roche, Peru; Roche, Pakistan; Roche, Taiwan; Roche, Venezuela - Bezalip Retard
Actavis, Hong Kong; Actavis, New Zealand; Actavis, Sweden; Actavis Group, Austria; Aurobindo, Netherlands; Aurovitas, Portugal; Euro Registratie, Netherlands; Roche, Ecuador; Roche, Egypt; Roche, Oman; Sandoz, Argentina - Bezalip SR
Tribute, Canada - Bezalite
Heng Hsin, Taiwan - Bezapid
Sheng Chung Tang, Taiwan - Bezastad
Stada Arzneimittel, Austria - Bezastad retard
Stada Arzneimittel, Austria - Bezatol SR
Kissei Pharmaceutical, Japan - Bezilon
Century, Taiwan - Bezin
Shyh Dar, Taiwan - Bonalip
Shou Chan, Taiwan - Brufiza
Bruluart, Mexico - Caberzol
Actavis UK, United Kingdom - Cedur
Actavis, Belgium - Cedur retard
Actavis, Switzerland - Cegelin
Yung Chi, Taiwan - Chaze
Chin Teng, Taiwan - Chinsa
Yung Chang, Taiwan - Chinsalo
Pfoshen, Taiwan - Cloestin
Hwang's, Taiwan - Colibrate
Yung Sine, Taiwan - Decrilip
Sanbe, Indonesia - Difaterol Retard
Bial-Industrial Farmaceutica, Spain - Dyna-Bezafibrate
Pharma Dynamics, South Africa - Elpi Lip
Elea, Argentina - Epibeza
Eipico, Egypt - Eulip
Washington, Taiwan - Eulitop
Actavis, Belgium; Actavis, Spain - Eulitop Retard
Actavis, Spain - Evicta
Charoon Bhesaj, Thailand - Fevilon
Li Ta, Taiwan - Fibrazate XL
Sandoz, United Kingdom - Fibroxol
Aspen Labs, Mexico - Ligisin
Kojar, Taiwan - Lipitrol
Jaffar Pharmacy, Bahrain - Midenal L
Shiono Kemikaru, Japan - Neptalip Extend
Rayere, Mexico - Nimus
Tecnofarma, Chile - Norlip
Trima, Israel - Oralipin Retard
Royal Pharma, Chile - PMS-Bezafibrate
Pharmascience, Canada - Regadrin B
Berlin-Chemie, Romania - Sandoz Bezafibrate
Sandoz, South Africa - Saprame
Probiomed, Mexico - Susheu
Sinton, Taiwan - Vesturit L
Teva Seiyaku, Japan - Yi Zhi Te
Rotam Reddy, China - Zafibral
Medochemie Singapore, Singapore - Zafular
Medochemie, Vietnam
Glossary
Term | Definition |
---|---|
BAN | British Approved Name |
DCF | Dénomination Commune Française |
DCIT | Denominazione Comune Italiana |
IS | Inofficial Synonym |
JAN | Japanese Accepted Name |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
WHO | World Health Organization |
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.